Print

HVTN 040

Phase I safety and immunogenicity evaluation of an alphavirus replicon HIV subtype C gag vaccine (AVX101) in healthy HIV-1 uninfected adult volunteers

Trial Details:

I Completed
HIV Vaccine Trials Network (HVTN) July 01, 2003
AVX101 Venezuelan Equine Encephalitis gag C
AVX101 Viral Vector - Alphavirus
South Africa, USA 132
NCT00063778
https://www.clinicaltrials.gov/ct2/show/NCT00063778